Recent Finacing
Recent Raise
Nuron Biotech develops biologics and vaccines for neurodegenerative and infectious diseases, commercializes vaccines including Meningitec and HibTITER, and advances NU100 (interferon beta-1b) in Phase 3 for multiple sclerosis.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor